Nationwide study observes sex-based disparities in liver transplantation for hepatocellular carcinoma, highlighting the impact of NASH across patient populations.
The cause of liver disease is changing, but its impact on liver transplantation (LT) for hepatocellular carcinoma (HCC) in women and men is unclear. We performed a nationwide study to assess the prevalence and posttransplant survival outcomes of the various causes of liver disease in women and men with HCC.
No takes yet. Share an insight, caveat, or question.
Koh et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: